Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 1 , Pages 3-18, February 2010

Cancer genetics and reproduction

  • Helen Hanson, MBBS, MRCP (Clinical Research Fellow)

      Affiliations

    • Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 208 722 4000; fax: +44 208 722 4359.
  • ,
  • Shirley Hodgson, BM BCh, DM, FRCP (Professor of Cancer Genetics)

      Affiliations

    • Department of Clinical Genetics, St Georges Hospital, Blackshaw Road, Tooting, SW17 ORE, UK
    • Tel.: +44 208 725 5279, Fax: +44 208 725 3444.

published online 28 August 2009.

Cancers of the reproductive organs (i.e., ovaries, uterus and testes), like other cancers, occur as a result of a multi-stage interaction of genetic and environmental factors. A small proportion of cancers of the reproductive organs occur as part of a recognised cancer syndrome, as a result of inheritance of mutations in highly penetrant cancer susceptibility genes (e.g., BRCA1, BRCA2, MLH1 or MSH2). Recognition of individuals and families with inherited cancer predisposition syndromes and individuals at high risk due to familial cancer clustering is fundamentally important for the management and treatment of the current cancer and for future prevention of further cancers for the individual and their extended family.

Keywords: hereditary cancer syndrome, ovarian cancer, endometrial cancer, BRCA1, BRCA2, MLH1, MSH2, hereditary non-polyposis colon cancer, lynch syndrome

 

PII: S1521-6934(09)00103-5

doi:10.1016/j.bpobgyn.2009.08.002

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 1 , Pages 3-18, February 2010